Comparative efficacy of first- versus second-line CDK4/6 inhibition in hormone receptor-positive, HER2-negative metastatic breast cancer.
| Publicado en: | Breast Cancer Research Vol. 27; no. 1; pp. 1 - 14 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
8/13/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |